5-34929844-G-A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_001012339.3(DNAJC21):​c.25G>A​(p.Gly9Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000026 in 1,576,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G9G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 29)
Exomes 𝑓: 0.000025 ( 0 hom. )

Consequence

DNAJC21
NM_001012339.3 missense

Scores

9
8
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 3.98

Publications

2 publications found
Variant links:
Genes affected
DNAJC21 (HGNC:27030): (DnaJ heat shock protein family (Hsp40) member C21) This gene encodes a member of the DNAJ heat shock protein 40 family of proteins that is characterized by two N-terminal tetratricopeptide repeat domains and a C-terminal DNAJ domain. This protein binds the precursor 45S ribosomal RNA and may be involved in early nuclear ribosomal RNA biogenesis and maturation of the 60S ribosomal subunit. Mutations in this gene result in Bone marrow failure syndrome 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2017]
DNAJC21 Gene-Disease associations (from GenCC):
  • bone marrow failure syndrome 3
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Shwachman-Diamond syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.963

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAJC21NM_001012339.3 linkc.25G>A p.Gly9Arg missense_variant Exon 1 of 12 ENST00000648817.1 NP_001012339.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAJC21ENST00000648817.1 linkc.25G>A p.Gly9Arg missense_variant Exon 1 of 12 NM_001012339.3 ENSP00000497410.1 Q5F1R6-1

Frequencies

GnomAD3 genomes
AF:
0.0000397
AC:
6
AN:
151130
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000739
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000465
AC:
1
AN:
214834
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000103
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000246
AC:
35
AN:
1425418
Hom.:
0
Cov.:
31
AF XY:
0.0000226
AC XY:
16
AN XY:
709124
show subpopulations
African (AFR)
AF:
0.0000333
AC:
1
AN:
30054
American (AMR)
AF:
0.00
AC:
0
AN:
41628
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25030
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35322
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82996
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51772
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5358
European-Non Finnish (NFE)
AF:
0.0000301
AC:
33
AN:
1094690
Other (OTH)
AF:
0.00
AC:
0
AN:
58568
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000397
AC:
6
AN:
151130
Hom.:
0
Cov.:
29
AF XY:
0.0000136
AC XY:
1
AN XY:
73792
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41292
American (AMR)
AF:
0.00
AC:
0
AN:
15204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5118
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10266
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000739
AC:
5
AN:
67664
Other (OTH)
AF:
0.00
AC:
0
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000282
Hom.:
0
Bravo
AF:
0.0000302
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Apr 04, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.25G>A (p.G9R) alteration is located in exon 1 (coding exon 1) of the DNAJC21 gene. This alteration results from a G to A substitution at nucleotide position 25, causing the glycine (G) at amino acid position 9 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Mar 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 9 of the DNAJC21 protein (p.Gly9Arg). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DNAJC21-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
T;T;.;.
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.47
FATHMM_MKL
Benign
0.56
D
LIST_S2
Pathogenic
0.98
.;D;D;D
M_CAP
Pathogenic
0.66
D
MetaRNN
Pathogenic
0.96
D;D;D;D
MetaSVM
Uncertain
0.41
D
MutationAssessor
Pathogenic
2.9
M;M;M;M
PhyloP100
4.0
PrimateAI
Pathogenic
0.92
D
PROVEAN
Pathogenic
-4.8
.;D;D;.
REVEL
Pathogenic
0.78
Sift
Uncertain
0.022
.;D;D;.
Sift4G
Uncertain
0.019
.;D;D;.
Polyphen
1.0
D;D;D;.
Vest4
0.44, 0.49
MutPred
0.85
Gain of MoRF binding (P = 4e-04);Gain of MoRF binding (P = 4e-04);Gain of MoRF binding (P = 4e-04);Gain of MoRF binding (P = 4e-04);
MVP
0.91
MPC
0.34
ClinPred
0.99
D
GERP RS
3.1
PromoterAI
0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.63
gMVP
0.59
Mutation Taster
=46/54
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748031504; hg19: chr5-34929949; API